Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
I'm-Yunity is a mushroom-derived dietary supplement containing polysaccharopeptide (PSP) extracted from the *Coriolus versicolor* (Turkey Tail) mushroom. Developed by Professor Yang Qingyao, it is primarily used as an adjunct therapy for cancer support in both humans and animals (particularly dogs with hemangiosarcoma). PSP is believed to possess immunomodulatory properties, potentially enhancing the immune system's response during chemotherapy or radiation. While marketed as a supplement, it has been the subject of clinical research, including a notable study at the University of Pennsylvania School of Veterinary Medicine regarding its effects on canine hemangiosarcoma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on I'm-Yunity.